José-María Arguiñano
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
-
- Multiple Myeloma Research and Treatments 4
-
- Protein Degradation and Inhibitors 3
- Co-authors
- Miguel‐Teodoro Hernández (2 shared papers)Joan Bladé (3 shared papers)Juan José Lahuerta (3 shared papers)María‐Victoria Mateos (3 shared papers)Laura Rosiñol (4 shared papers)Albert Oriol (3 shared papers)Felipe Prósper (3 shared papers)Jesús F. San Miguel (3 shared papers)
- Journals
- Blood (1 paper)The Lancet Oncology (1 paper)European Journal of Cancer (1 paper)Clinical Lymphoma Myeloma & Leukemia (1 paper)
- Partner nations
- Spain
In The Last Decade
José-María Arguiñano
4 papers receiving 127 citations
Peers
Comparison fields: 5 of 19
- Hematology 125
- Oncology 55
- Molecular Biology 104
- Genetics 15
- Emergency Medicine 4
Countries citing papers authored by José-María Arguiñano
This map shows the geographic impact of José-María Arguiñano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José-María Arguiñano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José-María Arguiñano more than expected).
Fields of papers citing papers by José-María Arguiñano
This network shows the impact of papers produced by José-María Arguiñano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José-María Arguiñano. The network helps show where José-María Arguiñano may publish in the future.
Co-authors
The 25 scholars most cited alongside José-María Arguiñano, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 107 | |
| 2 | 2022 | 19 | |
| 3 | 2023 | 1 | |
| 4 | 2016 | 1 |
About José-María Arguiñano
José-María Arguiñano is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Infectious Diseases, having authored 4 papers that have together received 128 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer Treatment and Pharmacology (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper) and Peptidase Inhibition and Analysis (1 paper). The work is most often cited by research in Hematology (125 citations), Oncology (55 citations), Molecular Biology (104 citations), Genetics (15 citations) and Emergency Medicine (4 citations). José-María Arguiñano has collaborated with scholars based in Spain. Frequent co-authors include Miguel‐Teodoro Hernández, Joan Bladé, Juan José Lahuerta, María‐Victoria Mateos, Laura Rosiñol, Albert Oriol, Felipe Prósper, Jesús F. San Miguel, Luis Palomera and Javier de la Rubia. Their work appears in journals such as Blood, The Lancet Oncology, European Journal of Cancer and Clinical Lymphoma Myeloma & Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.